GE HealthCare Technologies
GEHC
Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them
Managers holding
7
In their latest 13F (Q3 2026)
See who
Value held
$3.7bn
Combined value at quarter end
Last quarter
5 bought
2 sold or trimmed
Fund portfolios
2
Funds holding it
See which
Price at Q2 ’26 end
$64.01
-10.1% in the quarter
Share price change by quarter
+20.4%Q3 ’24
-16.7%Q4 ’24
+3.2%Q1 ’25
-8.2%Q2 ’25
+1.4%Q3 ’25
+9.2%Q4 ’25
-13.2%Q1 ’26
-10.1%Q2 ’26
Managers holding it, by quarter
5Q4 ’23
5Q1 ’24
6Q2 ’24
5Q3 ’24
5Q4 ’24
5Q1 ’25
6Q2 ’25
6Q3 ’25
7Q4 ’25
7Q1 ’26
7Q2 ’26
0Q3 ’26
Who holds it
| Trian Fund Management | 4.7%$197m | Added +76194% |
| Omega Family Office (Leon Cooperman) | 2.4%$83.8m | Added +95% |
| Harris Associates (Oakmark) | 1.3%$981m | Trimmed -1.7% |
| Dodge & Cox | 1.3%$2.4bn | Added +21% |
| First Pacific Advisors (FPA) | 0.7%$53.0m | New |
| Semper Augustus | 0.0%$293k | Unchanged |
| First Eagle Investment Management | 0.0%$16k | Added +347% |
About the company
- Sector
- Health care · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
- Incorporated in
- Delaware
- Financial year ends
- 31 December
- Shares outstanding
- 452m at 22 Jul 2026
- SEC filings
- Annual reports and other filings on EDGAR
Revenue and profit
$18bn2021
$18bn2022
$20bn2023
$20bn2024
$21bn2025
| Year | Revenue | Net income |
|---|---|---|
| 2025 | $21bn | $2.1bn |
| 2024 | $20bn | $2.0bn |
| 2023 | $20bn | $1.6bn |
| 2022 | $18bn | $1.9bn |
| 2021 | $18bn | $2.2bn |
Sold out last quarter
- Horizon Kinetics in Q2 2026
In fund portfolios
| Dodge & Cox Global Stock FundDodge & Cox | 1.2% |
| FPA Crescent FundFirst Pacific Advisors (FPA) | 0.3% |